Skip to content

PrEP rollout recipients in France top 1000: full trial results report 97% effectiveness

Jean-Michel Molina presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com

Bone loss partially recovers after stopping PrEP, twice-yearly kidney monitoring is enough for most

Craig Wilson presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com

PrEP can further reduce the risk of HIV infection after a partner starts treatment

Jared Baeten presenting at AIDS 2016. Photo by Jan Brittenson, hivandhepatitis.com

HIV seroconversion is rare if Truvada PrEP is used consistently

Slide from Gilead presentation at ASM Microbe 2016.

American gay men’s use of condoms has been falling for a decade, regardless of serosorting or PrEP

Long-acting oral antiretroviral MK-8591 could represent 'paradigm shift' in HIV treatment and prophylaxis

High sexually transmitted infection rates among men on PrEP supports more frequent monitoring

Sarit Golub at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

Maraviroc may work as PrEP in combination with another drug – but probably not by itself

Roy Gulick presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

Expanding treatment and PrEP could prevent 185,000 new HIV infections, US CDC says

Expanding treatment and PrEP could prevent 185,000 new HIV infections, US CDC says